Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Colitis Gravis

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunnett, NW; Canals, M; Carbone, SE; DiCello, JJ; Eriksson, EM; Fichna, J; McQuade, RM; Nowell, CJ; Poole, DP; Rajasekhar, P; Saito, A; Sebastian, BW; Veldhuis, NA1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Colitis Gravis

ArticleYear
Inflammation-associated changes in DOR expression and function in the mouse colon.
    American journal of physiology. Gastrointestinal and liver physiology, 2018, 10-01, Volume: 315, Issue:4

    Topics: Animals; Benzamides; Colitis, Ulcerative; Colon; Endocytosis; Enkephalin, Leucine-2-Alanine; Enteric Nervous System; Female; Gastrointestinal Motility; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Oligopeptides; Piperazines; Receptors, Opioid, delta

2018